Alpha-Adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors.
Cardiovascular actions of central alpha-adrenergic and 5-hydroxytryptaminergic stimulants are discussed in terms of overall effects, correlation of various activities, receptor activation and side-effects. The involvement of opiate receptors in their actions is also examined.